EN DE
Watch Pes Camanchaca for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Pes Camanchaca (CAMANCHACA) fair value: what the stock is really worth

As of Nov 18, 2026: fair value (intrinsic value) of Pes Camanchaca stock CLP 98, price CLP 93, upside +6.3%, quality 66 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive CL · ISIN CL0001717116

PC Pes Camanchaca logo Thin data Nov 14, 2026

Pes Camanchaca

CAMANCHACA · SN

Cheap enough by our rule, solid company and rising price: meets all 3 rules.

Follow free in the weekly email
Quality 66/100 
Rising price (uptrend) 
Healthy Growth (revenue 5y +9.6 %/yr in USD) 
Low debt 
Generates free cash flow 
Ranks above peers (12/14) 
Costs just 8.1 times its yearly profit. 
Fair value 98.34 CLP · Fairly valued 
Thin margins · 5.7% net margin (TTM) 
Moderate moat 48/100
Peak profit dampened: 183.90 CLP → 98.34 CLP 
Thin data 
⟳ Cyclical
Watch Pes Camanchaca for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

93.00 CLP 27.08 CLP Fair Value 98.34 CLP Sep 2019 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.

How to read this chart

60‑month range 27.08 CLP – 93.00 CLP · fair‑value band 55.93 CLP – 127.84 CLP · the 92.50 CLP price screens below the 98.34 CLP fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.

Follow Pes Camanchaca in your weekly email

Every Wednesday you see whether Pes Camanchaca is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Camanchaca S.A. engages in the industrial fishing business in Chile, the United States, Mexico, Japan, Europe, and China. The company produces fishmeal, frozen and canned jack mackerel, langostino lobster, and fish oil in northern and southern Chile; and engages in salmon farming activities.

Show moreShow less

It is also involved in farming mussels, frozen horse mackerel, prawns, and shrimp, abalones, and shellfish, as well as logistics operations. In addition, the company exports fish and shellfish to approximately 50 countries.

The company was formerly known as Compañía Pesquera Camanchaca S.A. Camanchaca S.A. was founded in 1965 and is based in Santiago, Chile.

Stock analysis

Pes Camanchaca (CAMANCHACA) currently trades at 92.50 CLP, while our model-based Fair Value estimate is 98.34 CLP, so the stock looks roughly fairly valued today (gap 5.9%).

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 233.45 CLP per share, and 21 of the 26 models we run sit above the 92.50 CLP price.

Bear case: the Dividend Discount group reads lowest at 37.32 CLP, and 5 of the 26 models stay below the price. Data coverage for this calculation is low.

Scenario range: 55.93 CLP (bear) to 127.84 CLP (bull), the price of 92.50 CLP sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 66/100 (solid quality), in the Consumer Defensive sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Pes Camanchaca reported revenue of $854M in FY2025 versus $640M in FY2021, a compound +7.5%/yr. Reported net income was $41.7M in FY2025, compounding +48.7%/yr from FY2021.

Key figures

Market cap 384B CLP (≈ $383M) Small · P/E ratio 8.1 · P/S ratio 0.40 · EPS (TTM) 11.35 CLP · Net margin 4.9% · Return on equity 12.1% · Return on assets (EBIT) 7.0% (5-year average) · Operating margin 17.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (medium confidence).

What moves the price

The share trades about 1% below its 52-week high and 47% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at 6%, CAMANCHACA screens richer than that median.

Fair Value models

Bear 55.93 CLP Fair Value 98.34 CLP Bull 127.84 CLP
Price 92.50 CLP · Upside +6.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 11 months old). Earnings retained since then (10.04 CLP per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 84.48 CLP 135.92 CLP 205.32 CLP 79
Growth DCF 85.57 CLP 130.61 CLP 187.73 CLP 78
Owner Earnings 82.44 CLP 132.97 CLP 201.13 CLP 76
All 26 models by family
DCF Models
FCF DCF 84.48 CLP 135.92 CLP 205.32 CLP 79
Owner Earnings 82.44 CLP 132.97 CLP 201.13 CLP 76
5Y Revenue Exit 131.99 CLP 237.21 CLP 371.67 CLP 71
5Y EBITDA Exit 180.14 CLP 326.62 CLP 497.28 CLP 74
5Y P/E Exit 100.76 CLP 179.24 CLP 260.68 CLP 70
10Y Revenue Exit 105.99 CLP 192.70 CLP 308.92 CLP 65
10Y EBITDA Exit 139.81 CLP 250.22 CLP 397.46 CLP 67
10Y P/E Exit 92.84 CLP 155.41 CLP 230.68 CLP 63
Earnings-Based
Graham-Dodd 68.90 CLP 207.45 CLP 274.97 CLP 65
Lynch FV 65.05 CLP 92.92 CLP 120.80 CLP 61
PEG = 1.0 65.05 CLP 92.92 CLP 120.80 CLP 57
EPV 113.23 CLP 133.47 CLP 150.47 CLP 74
Dividend Discount
Gordon GGM 21.98 CLP 40.56 CLP 57.00 CLP 67
DDM Multi-Stage 21.98 CLP 34.07 CLP 43.21 CLP 67
Multiples
P/E Multiple 159.58 CLP 212.77 CLP 265.96 CLP 63
P/S Multiple 129.18 CLP 172.24 CLP 215.30 CLP 58
P/B Multiple 61.77 CLP 82.36 CLP 102.95 CLP 55
EV/EBIT 248.55 CLP 343.45 CLP 438.36 CLP 66
EV/EBITDA 271.23 CLP 373.70 CLP 476.16 CLP 67
EV/Revenue 167.04 CLP 254.13 CLP 341.22 CLP 53
Asset-Based
NCAV (Graham) 39.65 CLP 53.13 CLP 79.29 CLP 54
Growth DCF
Growth DCF 85.57 CLP 130.61 CLP 187.73 CLP 78
Rev-Margin DCF 131.99 CLP 236.41 CLP 354.77 CLP 71
Economic Profit
Residual Income 79.11 CLP 87.49 CLP 108.28 CLP 76
ROIC Compounder 117.47 CLP 149.12 CLP 185.34 CLP 72
Growth Earnings
Growth-Adj P/E 130.46 CLP 186.37 CLP 242.28 CLP 67

The fair value above starts from this blend and is adjusted for a cyclical peak year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 66/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 45
How much profit the company makes from its sales and capital
Quality Growth 67
Are margins and returns getting better?
Cashflow 56
Do the profits arrive as real cash?
Financial strength 58
Debt, balance sheet and risk of trouble
Investment 92
Does it invest with discipline instead of growing at any price?
Low Volatility 90
How calm the share price moves, does not count
Price momentum 75
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 97
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 80/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+5.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.6%
Start year 2020 (pandemic). Over 10 years: +6.9% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.1%
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+42.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+42.7%
Dividend (yield on the price)0.0%
2025 sits 90% above its own trend. The rate follows the median trend of the last 5 years, not that single year.

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+5.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +3.0% a year for the price.

Watch CAMANCHACA, get fair value alerts →

Compare Pes Camanchaca with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 298 stocks

Beats the industry median on 12/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 66 · Top 25%
Fair Value upside +6.3% · Above median
Profitability
Return on equity (12 months) 12.1% · Top 25%
Return on assets 4.8% · Above median
Net margin (12 months) 5.7% · Above median
Operating margin (12 months) 17.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 9.4% · Above median
Dividend yield (12 months) 0.0% · Bottom 25%
Balance sheet
Debt / equity 0.41× · Highest 25%

Valuation Multiplesvs Farm Products median · lower = cheaper

P/E (12 months) 8.1× · Cheapest 25%
P/B 1.02× · Cheaper than median
P/S (12 months) 0.43× · Cheapest 25%
Price / free cash flow (fiscal year) 10.3× · Cheaper than median
EV/EBITDA 3.7× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)42 · sector 26
FUTURE (revenue growth)47 · sector 22
PAST (return on equity)48 · sector 17
HEALTH (low debt)79 · sector 94
DIVIDEND (yield)0 · sector 42

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Charoen Pokphand Foods Public Company CPF 19.55 THB 41.23 THB +111% vs CAMANCHACA
Tyson Foods, Inc TSN $64.25 $91.17 +42% vs CAMANCHACA
Mowi ASA MOWI kr 226.00 kr 274.71 +22% vs CAMANCHACA
Muyuan Foods Group 002714 ¥44.45 ¥53.02 +19% vs CAMANCHACA
United Plantations Berhad 2089 31.64 MYR 34.69 MYR +10% vs CAMANCHACA
Archer-Daniels-Midland Company ADM $67.78 $61.55 −9% vs CAMANCHACA
Wens Foodstuff Group 300498 ¥17.54 ¥12.08 −31% vs CAMANCHACA
Fujian Wanchen Food Group 300972 ¥132.31 ¥88.62 −33% vs CAMANCHACA
Bunge Global SA BG $93.19 $61.59 −34% vs CAMANCHACA
SalMar ASA SALM kr 587.50 kr 260.28 −56% vs CAMANCHACA

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Pes Camanchaca: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Pes Camanchaca Fair Value". https://www.fairvalue-calculator.com/stock/CAMANCHACA

Frequently asked questions

Is Pes Camanchaca (CAMANCHACA) overvalued or undervalued?
As of Nov 14, 2026, our model estimates a fair value of 98.34 CLP versus a price of 92.50 CLP, about +6% upside (fairly valued).
What is the fair value of CAMANCHACA?
Our model-based fair value for Pes Camanchaca is 98.34 CLP (as of Nov 14, 2026), built from audited fundamentals. The current price: 92.50 CLP.
What is the quality score of CAMANCHACA?
Pes Camanchaca has a Quality Score of 66/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Pes Camanchaca (CAMANCHACA)?
We do not set a price target; the yardstick is the fair value of 98.34 CLP (as of Nov 14, 2026) from 26 valuation models. Cautious scenario 55.93 CLP, optimistic scenario 127.84 CLP. It is a calculation from audited fundamentals, not an analyst target.
What is the Pes Camanchaca stock forecast for 2026?
Our models put fair value at 98.34 CLP, about +6% upside versus a price of 92.50 CLP (fairly valued). Cautious scenario 55.93 CLP, optimistic scenario 127.84 CLP. The calculation is refreshed regularly with new filings.
What is the revenue of Pes Camanchaca (CAMANCHACA)?
Pes Camanchaca reported trailing-twelve-month revenue of about $896M (latest available figure, as of Nov 14, 2026).
What growth is priced into Pes Camanchaca (CAMANCHACA)?
For today's price to be fair in a discounted-cash-flow model, Pes Camanchaca would have to grow free cash flow by 5.5 % per year for five years (discount rate 10.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 9.6 % per year. As of Nov 14, 2026.
What discount rate (WACC) does the fair value of CAMANCHACA use?
Our models discount Pes Camanchaca at 10.6 %: a base by market capitalisation (small), damped by beta 0.35, country premium for Chile. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Pes Camanchaca that is +5.5 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.6 %) and the same formula as our fair value.
How much growth has Pes Camanchaca (CAMANCHACA) delivered so far?
Over the past 5 years revenue at Pes Camanchaca grew 9.6 % a year. The price currently implies free-cash-flow growth of +5.5 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Pes Camanchaca (CAMANCHACA) growing?
The median revenue growth in the sector is +4.0 % a year. That is the yardstick for the growth priced into Pes Camanchaca (+5.5 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Pes Camanchaca (CAMANCHACA)?
The free-cash-flow yield on the price is 9.72 %: that much free cash flow Pes Camanchaca produces per unit of market value. When it exceeds the discount rate of our models (10.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Pes Camanchaca (CAMANCHACA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Pes Camanchaca it is 98.34 CLP per share (as of Nov 14, 2026), against a price of 92.50 CLP. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Pes Camanchaca stock overvalued or undervalued in 2026?
As of Nov 14, 2026, CAMANCHACA trades below its calculated fair value: price 92.50 CLP, fair value 98.34 CLP, a gap of about +6% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CAMANCHACA?
No. The price is what the market pays today (92.50 CLP); the fair value is what the company's own numbers justify (98.34 CLP). For Pes Camanchaca the two are 5.84 CLP per share apart. That gap is exactly why we show both numbers side by side.
How much is Pes Camanchaca worth?
The market values Pes Camanchaca at about 384B CLP (market capitalisation, as of Nov 14, 2026). Per share that is 92.50 CLP; our models calculate a fair value of 98.34 CLP per share.
What do the bullish and bearish scenarios say about CAMANCHACA?
Our models span a range for Pes Camanchaca: cautious scenario 55.93 CLP, base 98.34 CLP, optimistic 127.84 CLP per share (as of Nov 14, 2026, price 92.50 CLP). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CAMANCHACA?
Pes Camanchaca trades at a price-to-earnings ratio of 8.1 (as of Nov 14, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 98.34 CLP is built from several models across several years. Other multiples: P/B 1.0, P/S 0.4, EV/EBITDA 3.7.
How solid is the balance sheet of Pes Camanchaca (CAMANCHACA)?
Balance-sheet figures for Pes Camanchaca (as of Nov 14, 2026): return on equity 12.1%, debt of 0.41 per unit of equity. They feed the Quality Score of 66/100, which measures business quality independently of the share price.
How far is CAMANCHACA from its 52-week high?
Pes Camanchaca trades at 92.50 CLP, about 1% below its 52-week high of 93.00 CLP and 47% above the low of 62.94 CLP (as of Nov 18, 2026). Distance from the high says nothing about value: that is what the fair value of 98.34 CLP is for.
Which stocks are comparable to Pes Camanchaca?
From the same area (Consumer Defensive) we also value Muyuan Foods Group, Archer-Daniels-Midland Company, Tyson Foods, Inc, Bunge Global SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Pes Camanchaca stock attractive at the current price?
The data as of Nov 14, 2026: price 92.50 CLP, calculated fair value 98.34 CLP (+6%), Quality Score 66/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CAMANCHACA calculated?
We run Pes Camanchaca through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 98.34 CLP builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.0% above its aggregate fair value. Pes Camanchaca currently trades 6% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Pes Camanchaca (CAMANCHACA)?
The closing price on Nov 18, 2026 was 92.50 CLP. Our model-based fair value is 98.34 CLP, about +6% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Pes Camanchaca right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (55.93 CLP to 127.84 CLP) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Pes Camanchaca

How large is the market capitalisation of Pes Camanchaca (CAMANCHACA)?
The market capitalisation of Pes Camanchaca is 384B CLP (≈ $383M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Pes Camanchaca (CAMANCHACA)?
The price-to-sales ratio of Pes Camanchaca is 0.40 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Pes Camanchaca (CAMANCHACA)?
Earnings per share at Pes Camanchaca are 11.35 CLP (price ÷ EPS = P/E 8.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Pes Camanchaca (CAMANCHACA)?
The net margin of Pes Camanchaca is 4.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Pes Camanchaca (CAMANCHACA)?
The return on equity (ROE) of Pes Camanchaca is 12.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Pes Camanchaca (CAMANCHACA)?
On an EBIT basis the return on assets of Pes Camanchaca is 7.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Pes Camanchaca (CAMANCHACA)?
The operating margin of Pes Camanchaca is 17.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Pes Camanchaca (CAMANCHACA)?
Revenue at Pes Camanchaca is growing 9.4% versus a year earlier (3y avg +5.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Pes Camanchaca (CAMANCHACA)?
Earnings per share at Pes Camanchaca are growing 35.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Pes Camanchaca (CAMANCHACA) carry?
The net debt of Pes Camanchaca is $149M (fiscal year 2025, ≈ 4.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Why does Pes Camanchaca meet the fair value rule although the fair value shown is lower?
Peak profit dampened: 183.90 CLP → 98.34 CLP. The latest annual profit is far above the years before, and such peaks rarely last. So we calculate cautiously with 98.34 CLP instead of 183.90 CLP. If the profit stays high, we ease the caution year by year. As in the backtest, the fair value rule checks the value before: +99% against the price.
Free · no account needed

Watch Pes Camanchaca in the live analysis

One click puts Pes Camanchaca on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.